These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 31694110)

  • 1. [The diagnostic value of serum KL-6 in connective tissue disease associated interstitial lung disease].
    Wu X; Wu LJ; Luo CN; Shi YM; Zou JM; Meng XY
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3172-3175. PubMed ID: 31694110
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
    Ma H; Lu J; Song Y; Wang H; Yin S
    BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of KL-6 for predicting the occurrence and severity of connective tissue disease-associated interstitial lung disease is not affected by CTD type or treatment.
    Xing H; Liang H
    PeerJ; 2024; 12():e17792. PubMed ID: 39131623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
    Kilinc AA; Arslan A; Yildiz M; Kucur M; Adrovic A; Barut K; Sahin S; Cokugras H; Kasapcopur O
    Rheumatol Int; 2020 Oct; 40(10):1701-1706. PubMed ID: 31784789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
    Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
    Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
    Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
    Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases: A meta-analysis.
    Zhong D; Wu C; Bai J; Hu C; Xu D; Wang Q; Zeng X
    Medicine (Baltimore); 2020 Apr; 99(16):e19695. PubMed ID: 32311947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
    Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
    BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum KL-6 as predictive and prognostic marker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
    El-Beheidy R; Domouky AM; Zidan H; Amer YA
    Reumatismo; 2021 Nov; 73(3):. PubMed ID: 34814656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KL-6 levels in the connective tissue disease population: typical values and potential confounders-a retrospective, real-world study.
    Zhou A; Tang H; Peng W; Wang Y; Tang X; Yang H; Lu R; Pan P
    Front Immunol; 2023; 14():1098602. PubMed ID: 37409133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort.
    Millan-Billi P; Castellví I; Martinez-Martinez L; Mariscal A; Barril S; D'Alessandro M; Franquet T; Castillo D
    Arch Bronconeumol; 2024 Jun; 60(6):350-355. PubMed ID: 38644152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
    Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
    Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis.
    Hong M; Yin X; Yan W; Guo W; Liu H; Yang H
    Biomol Biomed; 2024 Sep; 24(5):1105-1116. PubMed ID: 38743787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the clinical performance of the HISCL-5000 analyzer in the detection of Krebs von den Lungen-6 antigen and its diagnostic value in interstitial lung disease.
    Wang J; Huang Z; Xue M; Huang H; Zheng X; Zhong N; Sun B
    J Clin Lab Anal; 2020 Feb; 34(2):e23070. PubMed ID: 31691368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease.
    Takanashi S; Nishina N; Nakazawa M; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2019 Jun; 58(6):1034-1039. PubMed ID: 30624752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
    PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease.
    Ko UW; Cho EJ; Oh HB; Koo HJ; Do KH; Song JW
    PLoS One; 2020; 15(12):e0244114. PubMed ID: 33332430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
    Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
    Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of Krebs von den Lungen-6 as a promising marker for predicting occurrence and deterioration of systemic sclerosis-associated interstitial lung disease from a Chinese cohort.
    Cao XY; Hu SS; Xu D; Li MT; Wang Q; Hou Y; Zeng XF
    Int J Rheum Dis; 2019 Jan; 22(1):108-115. PubMed ID: 30592376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.